1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

Micromet Inc. (NASDAQ:MITI) Takeover under Investor Investigation

An investigation on behalf of investors of Micromet Inc. (NASDAQ:MITI) in connection with the takeover was announced and NASDAQ: MITI stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com

FOR IMMEDIATE RELEASE

 
 
mail@shareholdersfoundation.com
mail@shareholdersfoundation.com
PRLog (Press Release) - Jan. 29, 2012 - The announcement by Amgen that it intends to will acquire Micromet for $11 per share prompted an investigation for investors in Micromet Inc. (NASDAQ:MITI) shares concerning whether the offer to acquire Micromet and the buyout process are unfair to investors in NASDAQ:MITI shares.

Investors who purchased shares of Micromet Inc. (NASDAQ:MITI) prior to Jan. 26, 2012, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The investigations by law firms concern whether Micromet Inc, certain officers and directors, and/or others breached their fiduciary duties to Micromet (NASDAQ: MITI) investors in connection with the proposed acquisition.

On Jan. 26, 2012, Amgen (NASDAQ:AMGN) and Micromet, Inc. (NASDAQ:MITI) announced that the companies have entered into a merger agreement under which Amgen will acquire Micromet for $11 per share in cash or a transaction, which values Micromet at approximately $1.16 billion.


However, at least on analyst has set the high target price for NASDAQ:MITI shares at $12 per share, thus above the current offer.

Therefore the investigation for NASDAQ:MITI investors concerns whether the Micromet Board of Directors undertook an adequate sales process and in particular breached their fiduciary duties to Micromet Inc. (NASDAQ:MITI) shareholders by failing to adequately shop the Company before entering into this transaction. The investigation also focuses on whether offer by Amgen undervalues NASDAQ:MITI shares. A potential securities class action lawsuit would seek to maximize the amount of money and information Micromet (MITI) shareholders would receive in a buyout, so the law firm.

Those who are current investors in Micromet Inc. (NASDAQ:MITI) and purchased your NASDAQ:MITI shares prior to the announcement, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

# # #

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Photo:
http://www.prlog.org/11784261/1

--- End ---

Click to Share

Contact Email:
***@shareholdersfoundation.com Email Verified
Source:Shareholders Foundation, Inc.
Phone:+1-(858)-779-1554
Fax:+1-(858)-605-5739
Address:3111 Camino Del Rio North - Suite 423
Zip:92108
City/Town:San Diego
State/Province:California
Country:United States
Industry:Banking, Business, Finance
Tags:, NASDAQ:MITI, Micromet Inc, , , , ,
Shortcut:http://prlog.org/11784261
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Upcoming Press Releases...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
8.4K1.9K2.6K
Click to Share